{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:58:12Z","timestamp":1764784692175,"version":"build-2065373602"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fondazione Regionale per la Ricerca Biomedica","award":["Plagencell project"],"award-info":[{"award-number":["Plagencell project"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Malignant pleural mesothelioma (MPM) is a rare and aggressive malignancy that most commonly affects the pleural layers. MPM has a strong association with asbestos, mainly caused by exposure to its biopersistent fibers in at least 80% of cases. Individuals with a chronic exposure to asbestos might develop disease with a 20\u201340-year latency with few or no symptoms. Such has been the case in the Italian regions of Piedmont and Lombardy, where industrial production of materials laden with asbestos, mainly cements, has been responsible for the onset of a large epidemic. Since 2018, a multidisciplinary team at San Matteo hospital in Pavia has been collecting data on over 100 patients with MPM. The main goal of this project is to define and describe an integrated profile for each MPM case at diagnosis by using data mining and partition analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Here we bring together exhaustive epidemiologic, histologic and radiologic data of 88 MPM patients that came to our observation and draw correlations with predictive and prognostic significance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The median overall survival (OS) was 15.6\u2009months. Most patients presented with pleural effusion, irrespective of disease stage. Quite unexpectedly, no statistically significant association was demonstrated between OS and TNM disease stage at diagnosis. Although average OS is similar in male and female patients, partition analysis of data underlined a significant differential hierarchy of predictor categories based on patient gender. In females with no smoking history, full chemotherapeutic regimens are associated with better outcomes. Moreover, concerning second line treatments, vinorelbine emerged as the most advantageous choice for female patients, whereas in the male subgroup no statistically significant difference resulted between gemcitabine and vinorelbine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A multidisciplinary approach to MPM is mandatory to define better therapeutic approaches, personalize the management and improve patient outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08532-x","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T16:05:20Z","timestamp":1625155520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Laura","family":"Saracino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra","family":"Bortolotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Tomaselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elia","family":"Fraolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Bosio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Accordino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Agustoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Eleftheriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Morbini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"Primiceri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Lancia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Comoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea R.","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0929-4394","authenticated-orcid":false,"given":"Giulia M.","family":"Stella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"issue":"1","key":"8532_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12885-015-1363-1","volume":"15","author":"Y Pignochino","year":"2015","unstructured":"Pignochino Y, Dell'Aglio C, Inghilleri S, Zorzetto M, Basiric\u00f2 M, Capozzi F, et al. The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma. BMC Cancer. 2015;15(1):374. https:\/\/doi.org\/10.1186\/s12885-015-1363-1.","journal-title":"BMC Cancer"},{"issue":"135","key":"8532_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1183\/09059180.00007014","volume":"24","author":"OD R\u00f8e","year":"2015","unstructured":"R\u00f8e OD, Stella GM. Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic. Eur Respir Rev. 2015;24(135):115\u201331. https:\/\/doi.org\/10.1183\/09059180.00007014.","journal-title":"Eur Respir Rev"},{"key":"8532_CR3","doi-asserted-by":"publisher","unstructured":"Berzenji L, Van Schil P. Multimodality treatment of malignant pleural mesothelioma. F1000Res. 2018 ;7: F1000 Faculty Rev-1681. doi: https:\/\/doi.org\/10.12688\/f1000research.15796.1.","DOI":"10.12688\/f1000research.15796.1"},{"issue":"6","key":"8532_CR4","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.jtho.2020.03.006","volume":"15","author":"J Remon","year":"2020","unstructured":"Remon J, Passiglia F, Ahn MJ, Barlesi F, Forde PM, Garon EB, et al. Immune checkpoint inhibitors in thoracic malignancies: review of the existing evidence by an IASLC expert panel and recommendations. J Thorac Oncol. 2020;15(6):914\u201347. https:\/\/doi.org\/10.1016\/j.jtho.2020.03.006.","journal-title":"J Thorac Oncol"},{"key":"8532_CR5","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3389\/fonc.2019.01519","volume":"9","author":"F Nicolini","year":"2020","unstructured":"Nicolini F, Bocchini M, Bronte G, Delmonte A, Guidoboni M, Crin\u00f2 L, et al. Malignant pleural mesothelioma: state-of-the-art on current therapies and promises for the future. Front Oncol. 2020;9:1519. https:\/\/doi.org\/10.3389\/fonc.2019.01519.","journal-title":"Front Oncol"},{"issue":"4","key":"8532_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3978\/j.issn.2225-319X.2012.11.04","volume":"1","author":"BM Robinson","year":"2012","unstructured":"Robinson BM. Malignant pleural mesothelioma: an epidemiological perspective. Ann Cardiothorac Surg. 2012;1(4):491\u20136. https:\/\/doi.org\/10.3978\/j.issn.2225-319X.2012.11.04.","journal-title":"Ann Cardiothorac Surg"},{"issue":"10","key":"8532_CR7","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2471\/BLT.11.086678","volume":"89","author":"V Delgermaa","year":"2011","unstructured":"Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ. 2011;89(10):716\u201324, 724A-724C. https:\/\/doi.org\/10.2471\/BLT.11.086678.","journal-title":"Bull World Health Organ"},{"issue":"9","key":"8532_CR8","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1183\/09031936.96.09091932","volume":"9","author":"JC McDonald","year":"1996","unstructured":"McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Respir J. 1996;9(9):1932\u201342. https:\/\/doi.org\/10.1183\/09031936.96.09091932.","journal-title":"Eur Respir J"},{"key":"8532_CR9","first-page":"307","volume":"4","author":"F Barbiero","year":"2016","unstructured":"Barbiero F, Giangreco M, Pisa FE, Negro C, Bovenzi M, Rosolen V, et al. Standardization of incidence rates of mesothelioma in the absence of national standards: sensitivity analysis in a cohort formerly exposed to asbestos. La Medicina del lavoro. 2016;4:307\u201314.","journal-title":"La Medicina del lavoro"},{"issue":"4","key":"8532_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/oemed-2016-104119","volume":"75","author":"A Marinaccio","year":"2018","unstructured":"Marinaccio A, Corfiati M, Binazzi A, Di Marzio D, Scarselli A, Ferrante P, et al. The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure. Occup Environ Med. 2018;75(4):254\u201362. https:\/\/doi.org\/10.1136\/oemed-2016-104119.","journal-title":"Occup Environ Med"},{"key":"8532_CR11","doi-asserted-by":"publisher","first-page":"108968","DOI":"10.1016\/j.envres.2019.108968","volume":"183","author":"D Consonni","year":"2020","unstructured":"Consonni D, De Matteis S, Dallari B, Pesatori AC, Riboldi L, Mensi C. Impact of an asbestos cement factory on mesothelioma incidence in a community in Italy. Environ Res. 2020;183:108968. https:\/\/doi.org\/10.1016\/j.envres.2019.108968.","journal-title":"Environ Res"},{"issue":"1","key":"8532_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/ijerph18010160","volume":"18","author":"E Oddone","year":"2020","unstructured":"Oddone E, Bollon J, Nava CR, Minelli G, Imbriani M, Consonni D, et al. Forecast of malignant peritoneal mesothelioma mortality in Italy up to 2040. Int J Environ Res Public Health. 2020;18(1):160. https:\/\/doi.org\/10.3390\/ijerph18010160.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"8532_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s40300-016-0088-5","volume":"74","author":"S Capecchi","year":"2016","unstructured":"Capecchi S, Iannario M. Gini heterogeneity index for detecting uncertainty in ordinal data surveys. METRON. 2016;74(2):223\u201332. https:\/\/doi.org\/10.1007\/s40300-016-0088-5.","journal-title":"METRON"},{"issue":"16","key":"8532_CR14","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1016\/j.physa.2010.03.045","volume":"389","author":"I Eliazar","year":"2020","unstructured":"Eliazar I, Sokolov IM. Maximization of statistical heterogeneity: from Shannon\u2019s entropy to Gini\u2019s index. Physica A. 2020;389(16):3023\u201338.","journal-title":"Physica A"},{"issue":"5","key":"8532_CR15","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3390\/cancers12051186","volume":"12","author":"DM Abbott","year":"2020","unstructured":"Abbott DM, Bortolotto C, Benvenuti S, Lancia A, Filippi AR, Stella GM. Malignant pleural mesothelioma: genetic and Microenviromental heterogeneity as an unexpected Reading frame and therapeutic challenge. Cancers (Basel). 2020;12(5):1186. https:\/\/doi.org\/10.3390\/cancers12051186.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"8532_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135798","volume":"10","author":"Y Ngamwong","year":"2015","unstructured":"Ngamwong Y, Tangamornsuksan W, Lohitnavy O, Chaiyakunapruk N, Scholfield CN, Reisfeld B, et al. Additive synergism between Asbestos and smoking in lung Cancer risk: a systematic review and meta-analysis. PLoS One. 2015;10(8):e0135798. https:\/\/doi.org\/10.1371\/journal.pone.0135798.","journal-title":"PLoS One"},{"issue":"9","key":"8532_CR17","first-page":"2263","volume":"51","author":"JE Muscat","year":"1991","unstructured":"Muscat JE, Wynder EL. Cigarette smoking, Asbestos exposure, and malignant mesothelioma. Cancer Res. 1991;51(9):2263\u20137.","journal-title":"Cancer Res"},{"issue":"1","key":"8532_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/PAT.0b013e32835bc848","volume":"45","author":"A Segal","year":"2013","unstructured":"Segal A, Sterrett GF, Frost FA, Shilkin KB, Olsen NJ, Musk AW, et al. A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit. Pathology. 2013;45(1):44\u20138. https:\/\/doi.org\/10.1097\/PAT.0b013e32835bc848.","journal-title":"Pathology."},{"issue":"5","key":"8532_CR19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.21873\/invivo.11360","volume":"32","author":"Y Negi","year":"2018","unstructured":"Negi Y, Kuribayashi K, Funaguchi N, Doi H, Mikami K, Minami T, et al. Early-stage Clinical Characterization of Malignant Pleural Mesothelioma. In Vivo. 2018;32(5):1169\u201374. https:\/\/doi.org\/10.21873\/invivo.11360.","journal-title":"In Vivo"},{"issue":"9","key":"8532_CR20","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.ejrad.2016.06.013","volume":"85","author":"K Kato","year":"2016","unstructured":"Kato K, Gemba K, Fujimoto N, Aoe K, Takeshima Y, Inai K, et al. Pleural irregularities and mediastinal pleural involvement in early stages of malignant pleural mesothelioma and benign asbestos pleural effusion. Eur J Radiol. 2016;85(9):1594\u2013600. https:\/\/doi.org\/10.1016\/j.ejrad.2016.06.013.","journal-title":"Eur J Radiol"},{"issue":"3","key":"8532_CR21","doi-asserted-by":"publisher","first-page":"934","DOI":"10.21037\/tlcr-2019-pps-10","volume":"9","author":"A Hjerpe","year":"2020","unstructured":"Hjerpe A, Abd Own S, Dobra K. Integrative approach to cytologic and molecular diagnosis of malignant pleural mesothelioma. Transl Lung Cancer Res. 2020;9(3):934\u201343. https:\/\/doi.org\/10.21037\/tlcr-2019-pps-10.","journal-title":"Transl Lung Cancer Res"},{"issue":"2","key":"8532_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.23750\/abm.v88i2.5558","volume":"88","author":"L Cardinale","year":"2017","unstructured":"Cardinale L, Ardissone F. Diagnostic Imaging and Workup of Malignant Pleural Mesothelioma. Acta Biomed. 2017;88(2):134\u201342. https:\/\/doi.org\/10.23750\/abm.v88i2.5558.","journal-title":"Acta Biomed"},{"issue":"1","key":"8532_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1148\/rg.241035058","volume":"24","author":"ZJ Wang","year":"2004","unstructured":"Wang ZJ, Reddy GP, Gotway MB, Higgins CB, Jablons DM, Ramaswamy M, et al. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics. 2004;24(1):105\u201319. https:\/\/doi.org\/10.1148\/rg.241035058.","journal-title":"Radiographics."},{"issue":"4","key":"8532_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.5812\/iranjradiol.8764","volume":"9","author":"O Tamer Dogan","year":"2012","unstructured":"Tamer Dogan O, Salk I, Tas F, Epozturk K, Gumus C, Akkurt I, et al. Thoracic computed tomography findings in malignant mesothelioma. Iran J Radiol. 2012;9(4):209\u201311. https:\/\/doi.org\/10.5812\/iranjradiol.8764.","journal-title":"Iran J Radiol"},{"key":"8532_CR25","unstructured":"Associazione Italiana di Oncologia Medica (AIOM), website at https:\/\/www.aiom.it\/wpcontent\/uploads\/2019\/10\/2019_LG_AIOM_Mesotelioma.pdf"},{"key":"8532_CR26","doi-asserted-by":"publisher","unstructured":"Berzenji L, Van Schil PE, Carp L. The eighth TNM classification for malignant pleural mesothelioma. Transl Lung Cancer Res. 2018; 7(5):543\u2013549. doi: https:\/\/doi.org\/10.21037\/tlcr.2018.07.05","DOI":"10.21037\/tlcr.2018.07.05"},{"issue":"4","key":"8532_CR27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s11864-014-0314-4","volume":"15","author":"D Gomez","year":"2014","unstructured":"Gomez D, Tsao AS. Local and systemic therapies for malignant pleural mesothelioma. Curr Treat Options in Oncol. 2014;15(4):683\u201399. https:\/\/doi.org\/10.1007\/s11864-014-0314-4.","journal-title":"Curr Treat Options in Oncol"},{"key":"8532_CR28","unstructured":"National Comprehensive Cancer Network (NCCN) website at, https:\/\/www.nccn.org\/store\/login\/login.aspx? ReturnURL=https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mpm.pdf"},{"issue":"3","key":"8532_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.lungcan.2015.06.018","volume":"89","author":"WA Buikhuisen","year":"2015","unstructured":"Buikhuisen WA, Hiddinga BI, Baas P, van Meerbeeck JP. Second line therapy in malignant pleural mesothelioma: a systematic review. Lung Cancer. 2015;89(3):223\u201331. https:\/\/doi.org\/10.1016\/j.lungcan.2015.06.018.","journal-title":"Lung Cancer"},{"issue":"5","key":"8532_CR30","doi-asserted-by":"publisher","first-page":"574","DOI":"10.21037\/tlcr.2018.04.10","volume":"7","author":"CJ de Gooijer","year":"2018","unstructured":"de Gooijer CJ, Baas P, Burgers JA. Current chemotherapy strategies in malignant pleural mesothelioma. Transl Lung Cancer Res. 2018;7(5):574\u201383. https:\/\/doi.org\/10.21037\/tlcr.2018.04.10.","journal-title":"Transl Lung Cancer Res"},{"key":"8532_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.envint.2014.10.016","volume":"74","author":"C Mensi","year":"2015","unstructured":"Mensi C, Riboldi L, De Matteis S, Bertazzi PA, Consonni D. Impact of an asbestos cement factory on mesothelioma incidence: global assessment of effects of occupational, familial, and environmental exposure. Environ Int. 2015;74:191\u20139. https:\/\/doi.org\/10.1016\/j.envint.2014.10.016.","journal-title":"Environ Int"},{"issue":"6","key":"8532_CR32","doi-asserted-by":"publisher","first-page":"1900953","DOI":"10.1183\/13993003.00953-2019","volume":"55","author":"A Scherpereel","year":"2020","unstructured":"Scherpereel A, Opitz I, Berghmans T, Psallidas I, Glatzer M, Rigau D, et al. ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur Resp J. 2020;55(6):1900953. https:\/\/doi.org\/10.1183\/13993003.00953-2019.","journal-title":"Eur Resp J"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08532-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08532-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08532-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T16:07:49Z","timestamp":1625155669000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08532-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8532"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08532-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"assertion":[{"value":"14 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. The study entered a main project that was approved by local Ethical Commission and each enrolled patient gave written informed consent before enrolment (Comitato di Bioetica, Fondazione IRCCS Policlinico San Matteo, approval numbers: protocol #20090002344; procedure # 20090019080; date of approval: June 3rd, 2009).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No specific informed consent needed. Informed consent for data management of each patients was collected routinely at hospital admission according to Institutional procedures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors have nothing to disclose","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"762"}}